8月3日，美因基因有限公司（股票代码：06667）公布2026年7月股份变动月报表。公告显示，截至2026年7月31日，公司法定/注册股本为500,000,000股普通股，每股面值0.0001美元，对应注册股本为50,000美元，较上月底无变化。
报告期末，公司总计已发行股份数为224,300,200股，其中流通股为223,532,200股，库存股数量由上月底的25,400股增至768,000股。本月内公司通过多次购回共计742,600股普通股，购回价格区间在每股6.19港元至7.42港元之间，所购回股份均暂列为库藏股，未进行注销操作。
月报未列示任何新增股份发行、股份期权或其他股权激励安排的变动，也无可换股票据、认股权证或其他相关协议的发行记录。公司声明当前公众持股量符合相关规定，并确认已遵守香港联交所《上市规则》及相关法律法规。本次公告由公司董事姜晶签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.